CURASCIENTIFIC CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | -.--% |
|
-50.00% | -75.00% |
| 02-09 | CuraScientific Corp. completed the acquisition of Sustainable Energy Group Inc for $5 million. | CI |
| 2023 | CuraScientific Corp. Announces Board Resignations | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Capitalization 1 | 0.004489 | 4.965 | 1.543 | 0.6659 |
| Enterprise Value (EV) 1 | 0.3721 | 5.731 | 2.579 | 3.303 |
| P/E ratio | - | -0.76 x | -0.11 x | -0.09 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 0.06 x | 82.5 x | 17.9 x | 19.3 x |
| EV / Revenue | 4.57 x | 95.3 x | 29.9 x | 95.9 x |
| EV / EBITDA | -53.3 x | -1.33 x | -0.62 x | -1.87 x |
| EV / FCF | - | -2,393,801 x | -20,175 x | -1,141,619 x |
| FCF Yield | - | -0% | -0% | -0% |
| Price to Book | - | -6.6 x | -0.02 x | -0.01 x |
| Nbr of stocks (in thousands) | 0.04 | 73.6 | 735 | 6,659 |
| Reference price 2 | 124.7 | 67.44 | 2.100 | 0.1000 |
| Announcement Date | 12/08/21 | 12/08/21 | 14/04/22 | 17/04/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net sales 1 | 0.0815 | 0.0602 | 0.0863 | 0.0344 |
| EBITDA 1 | -0.006975 | -4.297 | -4.165 | -1.763 |
| EBIT 1 | -0.018 | -4.308 | -4.776 | -2.38 |
| Operating Margin | -22.07% | -7,160.97% | -5,537.09% | -6,910.85% |
| Earnings before Tax (EBT) 1 | -0.2907 | -5.223 | -5.87 | -5.268 |
| Net income 1 | -0.2907 | -5.223 | -5.87 | -5.268 |
| Net margin | -356.84% | -8,682.67% | -6,805.12% | -15,299.16% |
| EPS | - | -88.48 | -19.32 | -1.115 |
| Free Cash Flow | - | -2.394 | -127.8 | -2.893 |
| FCF margin | - | -3,979.78% | -148,175.23% | -8,402.64% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 12/08/21 | 12/08/21 | 14/04/22 | 17/04/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net Debt 1 | 0.37 | 0.77 | 1.04 | 2.64 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | -52.7 x | -0.1783 x | -0.2487 x | -1.495 x |
| Free Cash Flow | - | -2.39 | -128 | -2.89 |
| ROE (net income / shareholders' equity) | - | 911% | 4.41% | 7.59% |
| ROA (Net income/ Total Assets) | - | -2,478% | -120% | -78.4% |
| Assets 1 | - | 0.2108 | 4.89 | 6.716 |
| Book Value Per Share | - | -10.20 | -86.90 | -10.60 |
| Cash Flow per Share | - | 0.0900 | 0.0300 | 0 |
| Capex | - | - | 0.01 | 0.01 |
| Capex / Sales | - | - | 6.51% | 43.31% |
| Announcement Date | 12/08/21 | 12/08/21 | 14/04/22 | 17/04/23 |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -75.00% | 553K | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
- Stock Market
- Equities
- CSTF Stock
- Financials CuraScientific Corp.
